Seminar – Matthew L. Banks, PharmD, PhD

Research interests: Medications development for opioid and psychostimulant addiction; Use of choice procedures in preclinical models of drug abuse; Neurobehavioral pharmacology

The overall theme of Dr. Banks' research centers on understanding the neurobehavioral mechanisms of drug choice over other competing non-drug reinforcers. The working hypothesis is that an effective treatment strategy, both pharmacological and behavioral, should facilitate reallocation of behavior away from drug choice toward choice of competing, alternative reinforcers. Ultimately the goal of his preclinical studies is to translate the results in developing efficacious clinical treatment strategies for drug addiction.